Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Nov 19, 2024 · 10-Q · 50 days after period end · 0001493152-24-046839
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$5.88M | -$3.90M | $1.61M | -$115.00 |
| EPS Diluted | -$0.03 | -$0.03 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 19, 2024 · 50 d after period end
